Paragon 28 introduced its R3ACT™ Stabilization System, designed to allow for multi-stage soft tissue healing following an acute or chronic syndesmotic injury to the ankle.
The system received FDA 510(k) marketing clearance in January 2022.
Paragon 28’s CEO, Albert DaCosta, said, “Since the inception of Paragon 28, the development of a syndesmotic stabilization system for ankle injuries has been a top priority for us. We believe this unique and proprietary product addresses the complexities of this indication and mimics not only the dynamic environment, but also transitions the function of stabilization to best match the healing phases of the soft tissues.
“Approximately 20% of all ankle injuries require implants for soft tissue healing. As a result, we believe the R3ACT™ Stabilization System will be a nice complement to our entire ankle fracture portfolio.”
Source: Paragon 28, Inc.
Paragon 28 introduced its R3ACT™ Stabilization System, designed to allow for multi-stage soft tissue healing following an acute or chronic syndesmotic injury to the ankle.
The system received FDA 510(k) marketing clearance in January 2022.
Paragon 28’s CEO, Albert DaCosta, said, “Since the inception of Paragon 28, the development of a...
Paragon 28 introduced its R3ACT™ Stabilization System, designed to allow for multi-stage soft tissue healing following an acute or chronic syndesmotic injury to the ankle.
The system received FDA 510(k) marketing clearance in January 2022.
Paragon 28’s CEO, Albert DaCosta, said, “Since the inception of Paragon 28, the development of a syndesmotic stabilization system for ankle injuries has been a top priority for us. We believe this unique and proprietary product addresses the complexities of this indication and mimics not only the dynamic environment, but also transitions the function of stabilization to best match the healing phases of the soft tissues.
“Approximately 20% of all ankle injuries require implants for soft tissue healing. As a result, we believe the R3ACT™ Stabilization System will be a nice complement to our entire ankle fracture portfolio.”
Source: Paragon 28, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.